Citations

Showing 10 of 108094 citations.

Author response: Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity
Yarzabek, Brogan , Olson, Eli , Silva, Gayathri N. , Geretz, Aviva , Thomas, Rasmi , Krishnakumar, Sujatha , Ramón, Daniel S. , Zaitouna, Anita , Geng, Jie , Raghavan, Malini

Mayo Clinic

No container title available | July 10, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.34961.051 Get It

Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity
Yarzabek, Brogan , Zaitouna, Anita , Olson, Eli , Silva, Gayathri N. , Geng, Jie , Geretz, Aviva , Thomas, Rasmi , Krishnakumar, Sujatha , Ramón, Daniel S. , Raghavan, Malini , Zaitouna, Anita J , Raghavan, Malini

Mayo Clinic

eLife | July 10, 2018 | Volume: 7 | Issue: No issue available | Pages: No page available

10.7554/elife.34961 | PMID 29989547 Get It

The highly polymorphic human leukocyte antigen (HLA) class I molecules present peptide antigens to CD8+ T cells, inducing immunity against infections and cancers. Quality control mediated by peptide loading complex (PLC) components is expected to ensure the cell surface expression of stable peptide-HLA class I complexes. This is exemplified by HLA-B*08:01 in primary human lymphocytes, with both expression level and half-life at the high end of the measured HLA-B expression and stability hierarchies. Conversely, low expression on lymphocytes is measured for three HLA-B allotypes that bind peptides with proline at position 2, which are disfavored by the transporter associated with antigen processing. Surprisingly, these lymphocyte-specific expression and stability differences become reversed or altered in monocytes, which display larger intracellular pools of HLA class I than lymphocytes. Together, the findings indicate that allele and cell-dependent variations in antigen acquisition pathways influence HLA-B surface expression levels, half-lives and receptivity to exogenous antigens.
Interventions for the treatment of brain radionecrosis after radiotherapy or radiosurgery
Chung, Caroline , Bryant, Andrew , Brown, Paul D.

Mayo Clinic

Cochrane Database of Systematic Reviews | July 10, 2018 | Volume: 2018 | Issue: 7 | Pages: No page available

10.1002/14651858.cd011492.pub2 | PMID 29987845 Get It

Autoimmune septin-5 cerebellar ataxia
Honorat, Josephe A., López‐Chiriboga, A. Sebastian , Kryzer, Thomas J., Fryer, James P., Devine, Michelle F., Flores, Angela, Lennon, Vanda A. , Pittock, Sean J. , McKeon, Andrew , Devine, Michelle, Pittock, S J , McKeon, Andrew

Mayo Clinic

Neurology Neuroimmunology & Neuroinflammation | July 9, 2018 | Volume: 5 | Issue: 5 | Pages: No page available

10.1212/nxi.0000000000000474 | PMID 29998156 Get It

Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases
Gentile, Massimo , Reda, Gianluigi , Mauro, Francesca Romana , Rossi, Davide , Renzo, Nicola Di , Molica, Stefano , Angrilli, F., Chiarenza, Annalisa , Cutrona, Giovanna , Chaffee, Kari G. , D’Arrigo, Graziella , Vigna, Ernesto , Recchia, Anna Grazia , Gaïdano, Gianluca , Raimondo, Francesco Di , Fais, Franco , Foà, Robin , Neri, Antonino , Rabe, Kari G. , Gentile, Massimo , Reda, Gianluigi , Mauro, Francesca R , Molica, Stefano , Chiarenza, Annalisa , Gaidano, Gianluca , Morabito, Fortunato , Shanafelt, Tait D. , Parikh, Sameer A. , Tripepi, Giovanni Luigi , Cortelezzi, Agostino , Ferrarini, Manlio

Mayo Clinic

American Journal of Hematology | July 9, 2018 | Volume: 93 | Issue: 9 | Pages: No page available

10.1002/ajh.25206 | PMID 29984867 Get It

Integration of MRI target delineation into rapid workflow cervical cancer brachytherapy: Impact on clinical outcomes
Dutta, Sunil W. , Pugh, Kelly J., Romano, Kara D. , Libby, Bruce, Trifiletti, Daniel M. , Showalter, Timothy N.

Mayo Clinic

Journal of Medical Imaging and Radiation Oncology | July 9, 2018 | Volume: 62 | Issue: 5 | Pages: 716-725

10.1111/1754-9485.12763 | PMID 29984892 Get It

AbstractIntroductionWe evaluated the impact of MRI‐based target delineation on toxicity and tumour control after implementation of a protocol to incorporate MRI while minimizing impact on overall procedural time.MethodsWe retrospectively reviewed outcomes for a cohort of 96 consecutive patients who received intracavitary brachytherapy for cervical cancer at our institution during 2012–2016. Starting in October 2014, an outpatient MRI was obtained for patients after Smit sleeve placement and first insertion to assess concurrent chemoradiotherapy tumour response. Then, for subsequent fractions, the MRI was co‐registered by the Smit sleeve to the planning CT for target volume delineation. The primary and secondary outcomes were toxicity and local control, respectively.ResultsMedian follow‐up for the pre‐ (n = 50) and post‐MRI‐based (n = 46) planning groups was 24.6 and 14.7 months, respectively. Median treatment duration for patients before and after MRI implementation was 56 and 58 days (P = 0.052), respectively. Cumulative rectal D2 cc was less for those with MRI‐based target delineation (P = 0.005). On multivariable analysis, patients with MRI‐based target delineation experienced fewer severe late (CTCAE grade ≥ 3) toxicities (P = 0.025, hazard ratio = 0.25). Local control was 86% and 91% of the pre‐ and post‐MRI groups, respectively (P = 0.959).ConclusionsPreliminary findings using this technique, which is applicable to other institutions without in‐room MRI availability, are associated with lower radiation prescription doses, lower rectal doses and favourable toxicity rates while maintaining a rapid workflow. Longer follow‐up is required to confirm equivalent local control.
Slow and Unsteady in the Fast Lane
Witt, Chance M. , Asirvatham, Samuel J. , Asirvatham, Samuel J

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | July 9, 2018 | Volume: 11 | Issue: 7 | Pages: No page available

10.1161/circep.118.006583 | PMID 29986949 Get It

Objective but Not Subjective Short Sleep Duration Is Associated With Hypertension in Obstructive Sleep Apnea
Ren, Rong , Covassin, Naima , Yang, Linghui , Zhang, Ye , Zhou, Junying , Tan, Lu, Li, Taomei , Li, Xiao , Wang, Yanyan , Zhang, Jihui , Tang, Xiangdong , Tang, Xiangdong , Li, Yun , Tan, Lu, Wing, Yun Kwok , Li, Weimin , Somers, Virend K.

Mayo Clinic

Hypertension | July 9, 2018 | Volume: 72 | Issue: 3 | Pages: 610-617

10.1161/hypertensionaha.118.11027 | PMID 29987105 Get It

Extremes of sleep duration and obstructive sleep apnea (OSA) are both associated with hypertension. We aimed to explore whether sleep duration modifies the relationship between OSA and prevalent hypertension, using both objective and subjective measures of total sleep duration. A total of 7107 OSA patients and 1118 primary snorers were included in the study. Hypertension was defined based either on direct blood pressure measures or on diagnosis by a physician. Objective sleep duration was derived by polysomnography and subjective sleep duration was self-reported. Logistic regression models were used to estimate the associations between objective/subjective sleep duration and hypertension prevalence in OSA and primary snorers. Compared with primary snorers, OSA combined with objective sleep duration of 5 to 6 hours increased the odds of hypertension by 45% (odds ratio, 1.45; 95% confidence interval, 1.14–1.84), whereas OSA combined with objective sleep duration <5 hours further increased the odds of hypertension by 80% (odds ratio, 1.80; 95% confidence interval, 1.33–2.42). These results were independent of major confounding factors frequently associated with OSA or hypertension. In stratified analysis by sleep duration, risk of hypertension in those with extremely short sleep (<5 hours) was not significantly different between OSA and primary snorers, whereas odds were significant for OSA in the other 4 sleep duration strata (5–6, 6–7, 7–8, and >8 hours). No significance was evident using subjective sleep duration. We conclude that objective short sleep duration is associated with hypertension in OSA patients. Extremely short sleep duration in itself may actually be even more detrimental than OSA in terms of hypertension risk.
Intraoperative use of low volume ventilation to decrease postoperative mortality, mechanical ventilation, lengths of stay and lung injury in adults without acute lung injury
Guay, Joanne, Ochroch, E. Andrew, Kopp, Sandra L.

Mayo Clinic

Cochrane Database of Systematic Reviews | July 9, 2018 | Volume: 2018 | Issue: 10 | Pages: No page available

10.1002/14651858.cd011151.pub3 | PMID 29985541 Get It